Modalités de prescription des inhibiteurs de la phospodiestérase de type 5 = Phosphodiesterase type 5 inhibitors: modalities of prescriptionDELAVIERRE, Dominique.Andrologie (Lille). 2004, Vol 14, Num 2, pp 239-241, issn 1166-2654, 3 p.Article

Rechallenge prior sildenafil nonrespondersJIANN, B.-P; YU, C.-C; SU, C.-C et al.International journal of impotence research. 2004, Vol 16, Num 1, pp 64-68, issn 0955-9930, 5 p.Article

Differential inhibitor sensitivity between human recombinant and native photoreceptor cGMP-phosphodiesterases (PDE6s)JI ZHANG; KUVELKAR, Reshma; PING WU et al.Biochemical pharmacology. 2004, Vol 68, Num 5, pp 867-873, issn 0006-2952, 7 p.Article

Sildenafil and pharmaco-penile duplex ultrasonography by Speel et al: inconclusive resultsSLOB, A. K; DOHLE, G. R; INCROCCI, L et al.International journal of impotence research. 2002, Vol 14, Num 2, pp 136-137, issn 0955-9930Article

Effect of sildenafil on nocturnal erections of potent menYAMAN, Ö; TOKATH, Z; INAL, T et al.International journal of impotence research. 2003, Vol 15, Num 2, pp 117-121, issn 0955-9930, 5 p.Article

Colorimetric Determination of Sildenafil Citrate (Viagra) Through Ion-Associate Complex FormationAMIN, Alaa S; MOUSTAFA, Moustafa E; EL-DOSOKY, Reham M. S et al.Journal of AOAC International. 2009, Vol 92, Num 1, pp 165-170, issn 1060-3271, 6 p.Article

Use of a Hydrolytic Procedure and Spectrometric Methods in the Structure Elucidation of a Thiocarbonyl Analogue of Sildenafil Detected as an Adulterant in an Over-the-Counter Herbal Aphrodisiac : Trans Fats: Update on Health Effects, Methodology, and Levels in Processed FoodsREEPMEYER, John C; D'AVIGNON, D. André.Journal of AOAC International. 2009, Vol 92, Num 5, pp 1336-1342, issn 1060-3271, 7 p.Article

Effects of sildenafil on nocturnal penile tumescence and rigidity in normal men: Randomized, placebo-controlled, crossover studyROCHIRA, Vincenzo; GRANATA, Antonio R. M; BALESTRIERI, Antonio et al.Journal of andrology. 2002, Vol 23, Num 4, pp 566-571, issn 0196-3635Article

Hemiballism due to sildenafil useMARTI, Itxaso; MARTI MOSSO, J. F.Neurology. 2004, Vol 63, Num 3, issn 0028-3878, p. 534Article

Sildenafil, N-desmethyl-sildenafil and Zaprinast enhance photoreceptor response in the isolated rat retinaBARABAS, Péter; RIEDL, Zsuzsanna; KARDOS, Julianna et al.Neurochemistry international. 2003, Vol 43, Num 6, pp 591-595, issn 0197-0186, 5 p.Article

Drug points: Tonic-clonic seizures in patients taking sildenafilGILAD, Ronit; LAMPL, Yair; ESHEL, Yehiel et al.BMJ. British medical journal (International ed.). 2002, Vol 325, Num 7369, issn 0959-8146, p. 869Article

Cardiovascular Data on Sildenafil CitrateZUSMAN, Randall M.The American journal of cardiology. 1999, Vol 83, Num 5A, issn 0002-9149, 48 p.Serial Issue

Use of intraurethral alprostadil in patients not responding to sildenafil citrateJAFFE, Jamison S; ANTELL, Mara R; GREENSTEIN, Marc et al.Urology (Ridgewood, NJ). 2004, Vol 63, Num 5, pp 951-954, issn 0090-4295, 4 p.Article

Metallothioneins I/II are involved in the neuroprotective effect of sildenafil in focal brain injuryPRADO, Judith; PIFARRE, Paula; GIRALT, Merce et al.Neurochemistry international. 2013, Vol 62, Num 1, pp 70-78, issn 0197-0186, 9 p.Article

Effect of Sildenafil on gastric emptying and postprandial frequency of antral contractions in healthy humansMADSEN, J. L; SØNDERGAARD, S. B; FUGLSANG, S et al.Scandinavian journal of gastroenterology. 2004, Vol 39, Num 7, pp 629-633, issn 0036-5521, 5 p.Article

Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)CORBIN, Jackie D; BEASLEY, Alfreda; BLOUNT, Mitsi A et al.Neurochemistry international. 2004, Vol 45, Num 6, pp 859-863, issn 0197-0186, 5 p.Conference Paper

Erectile dysfunction in essential arterial hypertension and effects of sildenafil: Results of a Spanish national studyARANDA, Pedro; RUILOPE, Luis M; CALVO, Carlos et al.American journal of hypertension. 2004, Vol 17, Num 2, pp 139-145, issn 0895-7061, 7 p.Article

The impact of sildenafil on molecular science and sexual health. Editorial commentBURNETT, Arthur L; GIULIANO, F; AVERSA, Antonio et al.European urology. 2004, Vol 46, Num 1, pp 9-14, issn 0302-2838, 6 p.Article

Type 5 phosphodiesterase inhibition by Sildenafil abrogates acute smoking-induced Endothelial dysfunctionVLACHOPOULOS, Charalambos; TSEKOURA, Dorothea; ALEXOPOULOS, Nikolaos et al.American journal of hypertension. 2004, Vol 17, Num 11, pp 1040-1044, issn 0895-7061, 5 p., 1Article

Physicochemical properties of Sildenafil citrate (Viagra) and Sildenafil baseMELNIKOV, Petr; CORBI, Pedro P; CUIN, Alexandre et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 10, pp 2140-2143, issn 0022-3549, 4 p.Article

Sildenafil: Emerging cardiovascular indicationsRAJA, Shahzad G; NAYAK, Suneela H.The Annals of thoracic surgery. 2004, Vol 78, Num 4, pp 1496-1506, issn 0003-4975, 11 p.Article

Urologie = UrologyJAYET, C; WISARD, M.Médecine et hygiène. 2003, Vol 61, Num 2419, pp 67-70, issn 0025-6749, 3 p.Article

Is the sildenafil product information adequate to facilitate informed therapeutic decisions?COHEN, Jay S.The Annals of pharmacotherapy. 2001, Vol 35, Num 3, pp 337-342, issn 1060-0280Article

Should patients be given an initial low test dose of sildenafil?COHEN, J. S.Drug safety. 2000, Vol 23, Num 1, pp 1-9, issn 0114-5916Article

Novel use of sildenafil in the treatment of portopulmonary hypertensionCHUA, Roderick; KEOGH, Anne; MIYASHITA, Masami et al.The Journal of heart and lung transplantation. 2005, Vol 24, Num 4, pp 498-500, issn 1053-2498, 3 p.Article